Brian Smith, PharmD, BCPS

Brian Smith, PharmD, BCPS Instructor

D r. Smith is currently the director of the pharmacy practice residency and a clincal pharmacy speciaist in critical care at UMass Memorial
Medical Center (UMMMC) where he practices in the surgical intensive
care unit. Dr. Smith is an adjunct assistant professor of pharmacy
practice at Massachussetts College of Pharmacy and Health Sciences. 
Dr. Smith is the chair of the pharmacy continuing education committee
and serves as a member of the critical care operations committee, nutrition
advisory committee, and on the medication management team at UMMMC  

E ducation

2003 Board Certified Pharmacotherapy Specialist (BCPS)
2000 Pharmacy Practice Residency, UMMMC
1999 Doctor of Pharmacy, Massachusetts College of Pharmacy and Health Sciences - Boston
1997 Bachelors of Science in Pharmacy, Massachusetts College of Pharmacy Health Sciences - Boston

Publications

Yogaratnam, D, Miller, MA, Smith, BS (2005)  The effects of liver and renal dysfunction on the pharmacokinetics of sedatives and analgesics in the critically ill patient.  Crit Care Nurs Clin N Am, 17, 245-250.

DeBellis, R, Smith, BS, Choi, S, Malloy, M (2005) Management of delirium tremens,  J Intensive Care Med, 20, 164-173.

Smith, BS, Schroeder, WS, Tataronis, GR (2005) Hospital reimbursement for Adult Patients with Severe Sepsis Treated with Drotrecogin Alfa (activated), Hosp Pharm, 40, 146-153.

Yogaratnam, D, Smith, BS, Angood, PB, Gandhi, PJ (2004) Antifactor Xa levels in four patients with burn injuries who received enoxaparin to prevent venous thromboembolism, Pharmacotherapy, 24, 1793-1799.

Smith, BS, Gandhi, PJ (2004) Ensuring the proper use of drotrecogin alfa (activated), Pharmacy Practice News, June, 28-29.

Saxer, SB, Smith, BS, Gandhi, PJ, Tataronis, G, Krikorian, S (2003) Lepirudin dosing in renal insufficiency: are we following the guidelines?  Am J Health-Syst Pharm,   60, 2588-93.

DeBellis, RJ, Smith, BS,

Cawley , PA , Burniski, GB.  Drug Dosing in Renal Failure in the Critically Ill.  In: Irwin, Cerra, Rippe, eds. Irwin and Rippie's Intensive Care Medicine. 5th ed.

Gandhi, PJ, Smith, BS, Maas , B, Tataronis, GR (2001) Impact of a Pharmacist on Drug Costs in a Coronary Care Unit, Am J Health-Syst Pharm, 58, 497-503. 

Smith, BS, Gandhi, PJ (2001) Dosing of LMWHs and IIb/IIIa Receptor Antagonists in Patients with Renal Failure, J Thromb Thrombolysis, 11, 39-48.

DeBellis, RJ, Smith, BS, Cawley , PA , Burniski, GB (2000) Drug Dosing in Renal Failure in the Critically Ill, J Intensive Care Med, 15, 273-313.

Smith BS, Summa MA (1999) Does Omeprazole Cause Fat Malabsorption? Nutr Clin Care, 2, 103-108

Research Interests

Pharmacokinetic and pharmacodynamic changes of medications in critically ill patients
Economic and clinical aspects of caring for patients with severe sepsis